PCOS Treatment Options in 2025: Medications, Lifestyle, and More

PCOS in 2025: More Options Than Ever Before

Polycystic ovary syndrome (PCOS) affects an estimated 8–13% of women of reproductive age globally — making it the most common hormonal disorder in this population. Despite its prevalence, PCOS has historically been poorly understood and undertreated. That is changing rapidly. In 2025, expanded medication options, refined diagnostic criteria, and better integration of lifestyle medicine have transformed PCOS management.

What Is PCOS? A Quick Refresher

PCOS is diagnosed using the Rotterdam criteria (two of three must be present): oligo- or anovulation, clinical or biochemical hyperandrogenism, and polycystic ovaries on ultrasound. Underlying drivers include insulin resistance (present in 65–80% of PCOS patients), chronic low-grade inflammation, dysregulated LH/FSH ratios, and excess androgen production from the ovaries and adrenal glands.

Lifestyle Interventions: The Foundation

Diet

Because insulin resistance is central to most PCOS cases, dietary interventions that reduce insulin demand have the most evidence:

• Low-glycemic index diet: Reduces post-meal insulin spikes that drive androgen production; studies show reductions in testosterone and improvements in menstrual regularity.
• Mediterranean diet: Anti-inflammatory and well-studied for metabolic syndrome; associated with improved fertility outcomes in PCOS.
• Reduced refined carbohydrates: Eliminating white bread, sugary beverages, and processed snacks is consistently beneficial.

Exercise

Even modest increases in physical activity dramatically improve insulin sensitivity in PCOS. Both resistance training and aerobic exercise improve menstrual regularity, reduce androgens, and support weight management. Aim for at least 150 minutes of moderate activity per week with 2–3 resistance sessions.

Weight Management

A 5–10% reduction in body weight can restore ovulatory function and improve all major PCOS features in women with overweight or obesity — often transformatively so.

Pharmacological Options

Hormonal Contraceptives

Combined oral contraceptives remain first-line for women not wishing to conceive with irregular periods, acne, or hirsutism. They regulate cycles, protect the uterine lining, increase SHBG (reducing free androgens), and improve acne. Anti-androgenic progestins (drospirenone) provide more benefit for androgen symptoms.

Metformin

Metformin improves insulin sensitivity, restores ovulation, reduces androgens, and improves metabolic markers. It is frequently combined with oral contraceptives to address different aspects of PCOS simultaneously.

GLP-1 Receptor Agonists

Semaglutide and liraglutide have become powerful PCOS tools — improving insulin resistance, producing meaningful weight loss, reducing androgen levels, and restoring ovulatory function. Multiple studies show dramatic improvements in menstrual regularity in women with PCOS on GLP-1 therapy. See our guide to GLP-1 medications and fertility for women with PCOS.

Anti-Androgen Medications

• Spironolactone: Blocks androgen receptors; highly effective for hirsutism and acne. Requires contraception in premenopausal women.
• Finasteride: 5-alpha reductase inhibitor that reduces DHT; sometimes used for PCOS-related hair loss.

Inositol Supplements

Myo-inositol and D-chiro-inositol are insulin sensitizers with a strong evidence base in PCOS, showing improved ovulation rate, reduced androgens, and improved insulin sensitivity — with an excellent safety profile. The 40:1 myo:D-chiro combination is widely used.

Fertility Treatment in PCOS

PCOS is the most common cause of anovulatory infertility. For women wishing to conceive:

• Letrozole: First-line ovulation induction (preferred over clomiphene per PCOSACT trial data).
• Clomiphene citrate: Still used but now second-line in most guidelines.
• Metformin + letrozole: Combination improves ovulation rates in clomiphene-resistant women.
• Gonadotropins and IVF: For non-responders to simpler treatments; PCOS patients typically have excellent egg reserve.

Long-Term Health Considerations

PCOS carries significant long-term metabolic implications requiring proactive management: 4–5x greater lifetime risk of type 2 diabetes, increased cardiovascular risk, elevated endometrial cancer risk from chronic anovulation, higher rates of anxiety and depression, and sleep apnea risk. Annual metabolic screening is recommended from diagnosis. Learn about medical weight management as part of long-term PCOS care.

A Personalized Approach

The best PCOS treatment plan is one tailored to your specific presentation — age, primary symptoms, fertility goals, metabolic status, and personal priorities. Working with a knowledgeable provider who understands the full complexity of PCOS is the single most important step toward achieving lasting results.